ARS Pharmaceuticals (SPRY) P/E (2020 - 2026)
ARS Pharmaceuticals (SPRY) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM ARS Pharmaceuticals (SPRY) P/E is -3.18. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of ARS Pharmaceuticals (SPRY)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.18 | -52.63% |
| 2025 | -6.72 | -104.91% |
| 2024 | 136.82 | -1721.49% |
| 2023 | -8.44 | -172.38% |
| 2022 | 11.66 | -202.41% |
| 2021 | -11.38 | -90.74% |
| 2020 | -122.94 | N/A |
Comparison ARS Pharmaceuticals (SPRY) P/E with competitors
ARS Pharmaceuticals (SPRY) P/E is -3.18.